QQ客服 官方微博 反馈留言

	1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase
	Mei-Jung Lai; Ritu Ojha; Mei-Hsiang Lin; Yi-Min Liu; Hsueh-Yun Lee; Tony Eight Lin; Kai-Cheng Hsu; Chi-Yen Chang; Mei-Chuan Chen; Kunal Nepali
刊名	European Journal of Medicinal Chemistry
	2019
卷号	Vol.162页码:612-630
关键词	Tubulin Indoline Benzamide HDAC Cancer
ISSN号	0223-5234
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4608457
专题	湖南大学
作者单位	1.b Ph.D. Program for Clinical Drug Development of Chinese Herbal Medicine, College of Pharmacy, Taipei Medical University, Taiwan a School of Pharmacy, College of Pharmacy, Taipei Medical University, 250 Wuxing Street, Taipei, 11031, Taiwan 2.The Ph.D. Program for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan 3.TMU Biomedical Commercialization Center, Taipei Medical University, Taiwan f National Institute of Cancer Research, National Health Research Institutes, Tainan, 704, Taiwan 4.Division of Hematology/Oncology, Department of Internal Medicine, National Cheng King University Hospital, College of Medicine, National Cheng King University, Tainan, Taiwan
推荐引用方式 GB/T 7714	Mei-Jung Lai,Ritu Ojha,Mei-Hsiang Lin,et al. 1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase[J]. European Journal of Medicinal Chemistry,2019,Vol.162:612-630.
APA	Mei-Jung Lai.,Ritu Ojha.,Mei-Hsiang Lin.,Yi-Min Liu.,Hsueh-Yun Lee.,...&Jing-Ping Liou.(2019).1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase.European Journal of Medicinal Chemistry,Vol.162,612-630.
MLA	Mei-Jung Lai,et al."1-Arylsulfonyl indoline-benzamides as a new antitubulin agents, with inhibition of histone deacetylase".European Journal of Medicinal Chemistry Vol.162(2019):612-630.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。